2nd International Conference on Endocrinology Skokie, IL - 60077

2nd International Conference on Endocrinology is categorized under Business Services (Unclassified) in Skokie, IL .

2nd International Conference on Endocrinology was established in 0, and today employs 1 to 4, earning Unknown per year. This is a Business Services (Unclassified) business, which does work in the B2B market, and is classified as a Business Services (Unclassified), under code number by the NAICS.

If you are seeking more information, feel free to contact at the company’s single location by writing to 9599 Skokie Boulevard, Skokie, Skokie, Illinois IL 60077 or by phoning (650) 268-9744. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.

Business Name: 2nd International Conference on Endocrinology
Address: 9599 Skokie Boulevard, Skokie, Skokie, Illinois 60077
Phone Number: (650) 268-9744
Annual Revenue (USD): Unknown
Location Type: Single Location
Employee Number: 1 to 4
Business Type: B2B (Business to Business)
Business Category: Business Services (Unclassified)
SIC Code: 7389
Share This Business:

2nd International Conference on Endocrinology was started in 0 to provide professional Business Services (Unclassified) under the SIC code 7389 and NAICS code . Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of Unknown per annum.

Feel free to contact for inquiries that concern 2nd International Conference on Endocrinology by calling the company number (650) 268-9744, as your correspondence is most welcome. Additionally, the physical location of the single location of 2nd International Conference on Endocrinology can be found at the coordinates 42.026448,-87.7470143 as well as the street address 9599 Skokie Boulevard, Skokie in Skokie, Illinois 60077.

For its online presence, you may visit 2nd International Conference on Endocrinology’s website at and engage with its social media outlets through on Twitter and on Facebook.